Lyme Disease and Health Care Costs
In this retrospective cohort study, LD presented a large financial burden to the health care system and patients, especially for those with disseminated disease. These findings highlight the need for effective preventive measures to reduce costs for patients and the health care system.
Authors
- J. J. Halperin
- Benjamin Chastek (ORCID: https://orcid.org/0000-0002-9759-6001)
- Mary G Johnson (ORCID: https://orcid.org/0000-0002-1115-0472)
- Holly Yu (ORCID: https://orcid.org/0000-0001-8625-4201)
- Brian T. Campfield (ORCID: https://orcid.org/0000-0002-5380-9837)
- Amanda R. Mercadante
- L. Hannah Gould
- Tim Bancroft
- Rebecca M. Fee
Institutions
- University of Pittsburgh (US)
- Pfizer (United States) (US)
- Overlook Medical Center (US)
- Optum (United States) (US)
- Children's Hospital of Pittsburgh (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.52518
- Primary Topic
- Vector-borne infectious diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer